Controlled Release of the Nimodipine-Loaded Self-Microemulsion Osmotic Pump Capsules: Development and Characterization
- 102 Downloads
The present study was intended to develop a controlled released osmotic pump capsule based on Nimodipine (NM)-loaded self-microemulsifying drug delivery systems (SMEDDSs) in order to improve the low oral bioavailability of NM. To optimize the NM-loaded SMEDDS composition, the experiments of NM solubility in different oils, the pseudo-ternary phase diagram experiments and the different drug loading experiments were conducted in the preliminary screening studies. Controlled release of NM required an osmotic pump capsule comprising a coated semi-permeable capsule shell, plasticizer, and pore-forming agent. NM release follows zero-order kinetics after oral administration. Polyethylene glycol content, used as a pore-forming agent, coating mass, and drug release orifice size were key factors affecting drug release behavior according to the single methods and were optimized through response surface methodology. The NM-loaded SMEDDS droplet size and the 1H NMR mass spectrogram of the novel capsule were determined. The droplet size of the reconstituted microemulsion was 39.9 nm and 1H NMR analysis showed NM dissolution in the microemulsion. The dissolution test performed on three batches of NM-SMEDDS capsules—prepared using optimal preparation methods—indicated the capsule to deliver a qualified drug delivery with a zero-order release rate. The results demonstrated that NM-loaded SMEDDSs were successfully developed and displayed a qualified release rate in vitro.
KEY WORDSosmotic pump controlled released capsule SMEDDS nimodipine 1H NMR
The authors are thankful to Prof. Li Ning from Guangdong Pharmaceutical University, for providing equipment used in this project and for consultation on analytical methods.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflicts of interest.
The use of self-microemulsifying drug delivery system (SMEDDS) solves the water insolubility problem of Nimodipine. Besides, osmotic pump systems (OPSs) can be used as a method to control formulation release by oral administration, whereby the drug release follows zero-order kinetics.
- 1.Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage British aneurysm nimodipine trial. BMJ. 1989;298(7764):636–42. https://doi.org/10.1136/bmj.298.6674.636.CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Al-Tamimi YZ, Orsi NM, Quinn AC, Homer-Vanniasinkam S, Ross SA. A review of delayed ischemic neurologic deficit following aneurysmal subarachnoid hemorrhage: historical overview, current treatment, and pathophysiology. World Neurosurg. 2010;73(6):654–67. https://doi.org/10.1016/j.wneu.2010.02.005.CrossRefPubMedGoogle Scholar
- 11.Bele S, Proescholdt MA, Hochreiter A, Schuierer G, Scheitzach J, Wendl C, et al. Continuous intra-arterial nimodipine infusion in patients with severe refractory cerebral vasospasm after aneurysmal subarachnoid hemorrhage: a feasibility study and outcome results. Acta Neurochir. 2015;157(12):2041–50. https://doi.org/10.1007/s00701-015-2597-z.CrossRefPubMedGoogle Scholar
- 12.Zhang XM, Wang M, Pei L, Wang AP, Liang RC, Gai YY, et al. Application of hot-melt extrusion technology for designing an elementary osmotic pump system combined with solid dispersion for a novel poorly water-soluble antidepressant. Pharm Dev Technol. 2016;21(8):1006–14. https://doi.org/10.3109/10837450.2015.1089896.CrossRefPubMedGoogle Scholar
- 16.Milovic M, Djuris J, Djekic L, Vasiljevic D, Ibric S. Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release. Int J Pharm. 2012;436(1–2):58–65. https://doi.org/10.1016/j.ijpharm.2012.06.032.CrossRefPubMedGoogle Scholar
- 24.Sermkaew N, Ketjinda W, Boonme P, Phadoongsombut N, Wiwattanapatapee R. Liquid and solid self-microemulsifying drug delivery systems for improving the oral bioavailability of andrographolide from a crude extract of Andrographis paniculata. Eur J Pharm Sci. 2013;50(3–4):459–66. https://doi.org/10.1016/j.ejps.2013.08.006.CrossRefPubMedGoogle Scholar
- 29.Banker GS, Rhodes CT. Modern pharmaceutics. In: Basic principles and systems. 4th ed. New York: Marcel Dekker Incorporated; 2002. p. 200–658.Google Scholar
- 30.Sci Finder Predicted NMR data calculated using Advanced Chemistry Development, Inc. (ACD/Labs) Software V11.01 (© 1994–2016 ACD/Labs) https://scifinder.cas.org/scifinder/view/scifinder/scifinderExplore.jsf/(accessed 12.7.31).